Archive for the ‘pain’ Category

Where has Dr. Don gone? Don’t miss this!

By Dr. Don | August 6th, 2009

I’m not gone. I have just decided that I need to use my knowledge to help people heal their conditions. We have been discussing what has been learned by Western medicine. But now that I have seen countless people healed of FMS, CFS, MCS, MS, pain, and other acute and chronic diseases with energy healing I feel compelled to work in this area! I am working with Quantum Techniques (QT) and getting amazing results. This is growing rapidly but I wanted to give my readers one last chance to receive a 30 minute toxin scan and discussion of your illness AT NO CHARGE.

First come first serve for 24 hours only…call my paging service at 877-704-6736 and press 5 to leave a number.

After reading the below I’ll hope you’ll take advantage of this offer.

New Research on Toxins in the Home

What did they do?

Researchers placed air collecting devices in 52 homes located in Arizona near the Mexico border. The samplers were put in various locations in the homes (kitchen, bathroom, living room, etc.) for 30 days.

Gas chromatography was used to identify individual chemicals in the air samples.

To confirm the measures, samples from 12 of the homes were further analyzed by gas chromatography-mass spectrometry (GC-MS). GC-MS is a highly sensitive method used to determine what and how much of a chemical is present in a sample. It is considered to be the “gold standard” in scientific analysis.

The analysis machines were configured to detect organochlorine pesticides, but other chemical groups of interest included polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs) and phthalates.
What did they find?

A total of 586 individual chemicals were identified. The pesticides diazinon and chlorpyrifos were found in the greatest amounts and both were found in all of the 52 homes tested.

Twenty-seven different organochlorine pesticides were detected. p,p’-DDE, a breakdown product of the now banned pesticide DDT, was detected in more than 90 percent of homes.

Amounts of PCBs were generally low but were found in more than half the houses. They were detected in 56 percent of the 52 homes studied.

Phthalate chemicals were found at very large concentrations in indoor air.

Researchers were not able to identify at least 120 of the chemicals. Many of these unidentified chemicals had structures similar to fragrance compounds. Fragrances made up the major chemical component of the collected chemicals.
What does it mean?

Since so many different types of chemicals were detected in the indoor air samples, the results point to a high potential for exposure to pesticides and other harmful chemicals in household air.

While not all of the chemicals could be identified, those that were represent a mix of chemical types. Animal studies and some human research have found various health effects from exposure to the chemicals found in the air. Long-term exposure to the individual compounds or the mixture could have potentially harmful health effects.

The results also indicate that people who live in these homes are routinely exposed to this potentially harmful mix of chemicals. It is likely this type of exposure is common and widespread in homes throughout the US.

The United States banned the household use of diazinon and chlorpyrifos several years ago. Despite this, these pesticides were detected at greater concentrations than other pesticides. Chlorpyrifos, though, is still used extensively in agriculture. The study highlights a need for identifying the sources of these pesticides in indoor air.

High levels of DDT and its breakdown products are also indicative of continued use in or near the residences. Although the use of DDT has been banned in the US and is being phased out in Mexico, the authors note that it continues to be used along the US border.

The main human exposure to phthalates is thought to be through direct contact with skin through personal care products (cosmetics, perfumes, etc.) or directly through medical tubes and devices. Following direct contact, phthalates travel through the skin or mouth and have been found at high concentrations in human plasma and urine (Swan et al. 2005).

This study supports prior studies that reveal people can be exposed to phthalates through dust and air. The high concentrations of phthalates found in indoor air indicate that breathing in the chemicals could be a significant route of exposure. Studies that have measured phthalates indoors have also linked those indoor air levels with asthma and possibly higher rates of autism in children who live with certain types of vinyl flooring that contains phthalates.

Detailed information about the houses and the residents was missing from the study. Additional facts – such as whether residents smoked in the home, whether the homes were air conditioned or whether the homes were ventilated through open windows – could be useful when trying to identify the sources of the chemicals.

In general, this study raises awareness of the types and amounts of chemicals present in indoor air. It is a first step in understanding the links between indoor chemical exposure and health problems that may result from the long-term exposures.
Resources

Bornehag CG, J Sundell, CJ Weschler, T Sigsgaard T, B Lundgren, M Hasselgren, L Hägerhed-Engman. 2004. The association between asthma and allergic symptoms in children and phthalates in house dust: a nested case-control study. Environmental Health Perspectives. 2004 Oct;112(14):1393-7.

Laetz, CA, DH Baldwin, TK Collier, V Hebert, JD Stark and NL Scholz. 2009. The synergistic toxicity of pesticide mixtures: implications for risk assessment and the conservation of endangered Pacific salmon. Environmental Health Perspectives doi: 10.1289/ehp.0800096.

Longnecker MP, WJ Rogan and G Lucier. 1997. The human health effects of DDT (dichlorodiphenyl-trichloroethane) and PCBs (polychlorinated biphenyls) and an overview of organochlorines in public health. Annual Review of Public Health 18: 211-244.

Swan SH, KM Main, F Liu, SL Stewart, RL Kruse, AM Calafat, CS Mao, JB Redmon, CL Ternand, S Sullivan, JL Teague and the Study for Future Families Research Team, 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives 113: 1056-1061.

Hippocampus and FMS-more brain abnormaities

By Dr. Don | July 9th, 2009

These findings are interesting as abnormal functioning of the hippocampus could contribute to fibro-fog, sleep disorders, and a heightened sensitivity and perception of pain—key symptoms in FMS/CFS. Hippocampal dysfunction may explain fibromyalgia syndrome symptoms and indicates that further research my lead to better treatments.

NEW YORK (Reuters Health) - A paper in the July issue of the Journal of Rheumatology suggests that hippocampus dysfunction may explain some symptoms of fibromyalgia syndrome.
Dr. Yasser Emad, of Cairo University, Egypt, and colleagues used proton magnetic resonance spectroscopy (1H-MRS) to examine hippocampal function in 15 patients with fibromyalgia syndrome and 10 healthy age-matched controls.
Using 1H-MRS, the researchers calculated hippocampal levels of N-acetyl aspartate (NAA), choline, creatine and their ratios and compared the findings between groups. All study participants also underwent assessments of sleep patterns, cognitive function, and symptoms of depression. The number of tender points was assessed in all patients, and a visual analog scale was used to measure pain.
Patient age averaged 35.7 years, and mean disease duration was 18.1 months. All patients had cognitive functional impairment on the Mini Mental State Examination, eight (35.5%) were depressed on the basis of the Hamilton Depression Scale, and nine (60%) had sleep disturbances. None of the control subjects had cognitive impairment, depression, or sleep disturbance.
“NAA levels of the right and left hippocampi were lower in the patients compared to controls (p = 0.05 and p < 0.003, respectively),” Dr. Emad’s team explains. “Another statistically significant difference was observed in choline levels in the right hippocampus, which were higher in the patient group.” Patients also had significantly lower NAA/choline and NAA/creatine ratios compared to controls.
There were no differences between groups in other measured metabolites or in the choline/creatine ratio.
In the patient group, language scores were significantly correlated with choline and creatine levels (p = 0.041 and p = 0.006, respectively), but there was no significant correlation between metabolites or their ratios and numbers of tender points, Fibromyalgia Impact Questionnaire score, or pain as assessed by the visual analog scores.
“The hippocampus was dysfunctional in patients with fibromyalgia, as shown by lower NAA levels…, representing neuronal or axonal metabolic dysfunction,” the investigators conclude. “As the hippocampus plays crucial roles in maintenance of cognitive functions, sleep regulation, and pain perception, we suggest that metabolic dysfunction of hippocampus may be implicated in the appearance of these symptoms associated with this puzzling syndrome.
J Rheumatol 2008;35:1371-1377.

Yours, Dr. Don

About Dr. Don Bailey | Blog | Resources | Contact Us | HopeMD.com Home